SNX-111. Antinociceptive agent N-type voltage-sensitive calcium channel blocker

Drugs of the Future

Volumn 23, Issue 2, 1998, Pages 152-160

  Bowersox, Scott ^a   Tich, Nancy ^a   Mayo, Martha ^a   Luther, Robert ^a  

^a Neurex Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINOCICEPTIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DILTIAZEM; DIZOCILPINE; DRUG VEHICLE; FORMALDEHYDE; MORPHINE; NIMODIPINE; OMEGA CONOTOXIN MVIIA; PLACEBO; SODIUM CHLORIDE; VERAPAMIL;

ALLODYNIA; ANALGESIC ACTIVITY; ANTINOCICEPTION; BURN; CALCIUM TRANSPORT; CLINICAL TRIAL; CONFUSION; DRUG POTENCY; HEADACHE; HOT PLATE TEST; HUMAN; INTRASPINAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MECHANICAL STIMULATION; MORPHINE TOLERANCE; NAUSEA; NERVE LIGATION; NONHUMAN; NYSTAGMUS; ORTHOSTATIC HYPOTENSION; PAIN; REVIEW; SPINAL NERVE; SUBCUTANEOUS DRUG ADMINISTRATION; SYNCOPE; VERTIGO; WITHDRAWAL REFLEX;

EID: 0031940072     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1998.023.02.443399     Document Type: Review

References (36)

1. Olivera, B.M., Miljanich, G.P., Ramachandran, J., Adams, M.E. Calcium channel diversity and neurotransmitter release: The ω-conotoxins and ω-agatoxins. Annu Rev Biochem 1994, 63: 823-67.
2. 2+ channel diversity. Annu Rev Neurosci 1994, 17: 399-418.
3. McCleskey, E.W. Calcium channels: Cellular roles and molecular mechanisms. Curr Opin Neurobiol 1994, 4: 304-12.
4. Wilson, T.W., Quest, D.W. Comparative pharmacology of calcium antagonists. Can J Cardiol 1995, 11: 243-9.
5. Olivera, B.M., Cruz, L.J., de Santos, V. et al. Neuronal calcium channel subtypes using ω-conotoxin from Conus magus venom. Biochemistry 1987, 26: 2086-90.
6. Miljanich, G.P., Ramachandran, J. Antagonists of neuronal calcium channels: Structure, function, and therapeutic implications. Ann Rev Pharmacol Toxicol 1995, 35: 707-34.
7. 2+ channels are located on somata, dendrites, and a subpopulation of dendritic spines on live hippocampal pyramidal neurons. J Neurosci 1995, 14: 6815-24.
8. Gaur, S., Newcomb, R., Rivnay, B., Bell, J.R., Ramachandran, J., Miljanich, G.P. Calcium channel antagonist peptides define several components of transmitter release in the hippocampus. Neuropharmacology 1994, 33: 1211-9.
9. Gohil, K., Bell, J.R., Ramachandran, J., Miljanich, G.P. Neuroanatomical distribution of receptors for a novel voltage-sensitive calcium channel antagonist, SNX-230 (omega-conopeptide MVIIC). Brain Res 1994, 653: 258-66.
10. Malmberg, A.B., Yaksh, T.L. Voltage-sensitive calcium channels in spinal nociceptive processing: Blockade of N-and P-type channels inhibits formalin-induced nociception. J Neurosci 1994, 14: 4882-90.
11. Malmberg, A.B., Yaksh, T.L. Effect of continuous intrathecal infusion of ω-conopeptides, N-type calcium channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 1995, 60: 83-90.
12. Randall, L.O., Selitto, J.J. A method for measurement of analgesic activity of inflamed tissue. Arch Int Pharmacodyn 1957, 11: 409.
13. Omote, K., Kawamata, M., Satoh, O., Iwasaki, H., Namiki, A. Spinal antinociceptive action of an N-type voltage-dependent calcium channel blocker and the synergistic interaction with morphine. Anesthesiology 1996, 84: 36-43.
14. Perkins, M.N., Campbell, E., Urban, L., Dray, A. Hyperalgesia induced by ultraviolet radiation in the rat: Differential sensitivity to morphine and ibuprofen. J Physiol (London) 1993, 459: 205P.
15. 1 neurokinin receptor activation and enhanced A-and C-fiber mediated responses in the rat spinal cord in vitro. J Neurosci 1994, 4: 3672-87.
16. Dubuisson, D., Dennis, S.G. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain-stem stimulation in rats and cats. Pain 1977, 4: 161-74.
17. Bowersox, S.S., Gadbois, T., Singh, T., Pettus, M., Wang, Y.-X., Luther, R.R. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent, and neuropathic pain. J Pharmacol Exp Ther 1996, 279: 1243-9.
18. Diaz, A., Dickenson, A.H. Blockade of spinal N-and P-type, but not L-type, calcium channels inhibits the excitability of rat dorsal horn neurones produced by subcutaneous formalin inflammation. Pain 1997, 69: 93-100.
19. Kim, S.H., Chung, J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50: 355-63.
20. Chaplan, S.R., Pogrel, J.W., Yaksh, T.L. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 1994, 269: 1117-23.
21. Bhargava, H.N. Enhancement of morphine actions in morphine-naive and morphine tolerant mice by LY 235959, a competitive antagonist of the NMDA receptor. Gen Pharmacol 1997, 28: 61-4.
22. Nichols, M.L., Lopez, Y., Ossipov, M.H., Bian, D., Porreca, F. Enhancement of the antiallodynia and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain 1997, 69: 317-22.
23. Nichols, M.L., Ossipov, M.H., Lai, J., Porreca, F. Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats. J Pharmacol Exp Ther 1995, 275: 1339-45.
24. 2 adrenoceptor agonists. J Pharmacol Exp Ther 1995, 273: 207-14.
25. Arner, S., Meyerson, B.A. Lack of analgesic effect on neuropathic and idiopathic forms of pain. Pain 1988, 33: 11-23.
26. Portenoy, R.K., Foley, K.M., Inturissi, C.E. The nature of opioid responsiveness and its implications in neuropathic pain: New hypotheses derived from studies of opioid infusions. Pain 1990, 43: 273-86.
27. Smith, F.L., Stevens, D.L. Calcium modulation of morphine analgesia: Role of calcium channels and intracellular pool calcium. J Pharmacol Exp Ther 1995, 272: 290-9.
28. Olivera, B.M., Gray, W.R., Zeikus, J.R., McIntosh, J.M., Varga, J., Rivier, J., de Santos, V., Cruz, L.J. Peptide neurotoxins from fish hunting cone snails. Science 1985, 203: 1338-43.
29. 2+-channel blocker omega-conotoxin in conscious rats. Amer J Physiol 1990, 259: R427-38.
30. Bowersox, S.S., Singh, T., Nadasdi, L., Zukowska-Grojec, Z., Valentino, K., Hoffman, B.B. Cardiovascular effects of ω-conopeptides in conscious rats: Mechanism of action. J Cardiovasc Pharmacol 1992, 20: 756-64.
31. Wang, Y.-X., Bezprozvannaya, S., Nadasdi, L., Mezo, D., Silva, R., Luther, R., Miljanich, G., Bowersox, S. Peripheral vs. central potencies of N-type calcium channel blocking ω-conopeptides. Soc Neurosci Abst 1995, 21 (Part 1): Abst 140.6.
32. McGuire, D., Bowersox, S., Fellmann, J.D., Luther, R.R. Sympatholysis after neuron-specific, N-type voltage sensitive calcium channel blockade: First demonstration of N-channel function in humans. J Cardiovasc Pharmacol 1997, 30: 400-3.
33. McGuire, D., Kugler, A., Bowersox, S., Luther, R.R.L. SNX-111 - The first N-type, voltage-sensitive calcium channel antagonist administered to humans: Pharmacokinetics and evidence of drug effect. Neurology 1996, 46(2, Suppl.): Abst P02.120.
34. Brose, W.G., Pfeifer, B.L., Hasenbusch, S.J., Burchiel, K.J., Byas-Smith, M., Krames, E., McGuire, D., Tich, N., Luther, R.R. Analgesia produced by SNX-111 in patients with morphine-resistant pain. 15th Annu Meet Amer Pain Soc (Nov 14-17, Washington DC) 1996.
35. Brose, W.G., Gutlove, D.P., Luther, R.R., Bowersox, S.S., McGuire, D. Use of intrathecal SNX-111, a novel N-type, voltage-sensitive calcium channel blocker, in the management of intractable brachial plexus avulsion pain. Clin J Pain 1997, 13: 256-9.
36. Dixon, W.J. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20: 441-62.